Task: Answer the multiple choice question.
Query: Which drug exhibits a 16.579\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) Cc1cccc2cc(C#N)c(SCC(=O)NCC3CCCO3)nc12
(b) COCCNC(=O)CSc1nc2sccc2c(=O)n1-c1ccccc1
(c) C=CCNC(N)=S
(d) CN(C)CCN1C(=O)C(O)=C(C(=O)c2cc3ccccc3o2)C1c1ccc(N(C)C)cc1
Answer: b. COCCNC(=O)CSc1nc2sccc2c(=O)n1-c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCNC(=O)CSc1nc2sccc2c(=O)n1-c1ccccc1
COCCNC(=O)CSc1nc2sccc2c(=O)n1-c1ccccc1
N-(2-methoxyethyl)-2-(4-oxo-3-phenylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide